These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9841040)

  • 1. Use of calcium channel blockers and risk of suicide. Perscriptions for particular drug are influenced by numerous factors.
    Chen YT; Makuch RW
    BMJ; 1998 Oct; 317(7165):1077. PubMed ID: 9841040
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of calcium channel blockers and risk of suicide. Drug perscriptions over longer period should have been followed up.
    Wiholm BE; Sundström A; Alfredsson L
    BMJ; 1998 Oct; 317(7165):1076-7. PubMed ID: 9841039
    [No Abstract]   [Full Text] [Related]  

  • 3. Using medication history to measure confounding by indication in assessing calcium channel blockers and other antihypertensive therapy.
    Leader S; Mallick R; Roht L
    J Hum Hypertens; 2001 Mar; 15(3):153-9. PubMed ID: 11317198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suicide link with blood pressure drug unproven.
    Health News; 1998 Apr; 4(5):7. PubMed ID: 9563303
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium-channel blockers and cancer.
    Oliver S
    Lancet; 1996 Oct; 348(9035):1165; author reply 1167. PubMed ID: 8888181
    [No Abstract]   [Full Text] [Related]  

  • 6. [The safety of Calcium channel blockers].
    Leinonen H
    Duodecim; 1996; 112(21):1961-2. PubMed ID: 10605196
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of calcium channel blockers and risk of suicide. Independent studies are needed before causality is established.
    Bergman U; Isacsson G
    BMJ; 1998 Oct; 317(7165):1076. PubMed ID: 9774303
    [No Abstract]   [Full Text] [Related]  

  • 8. The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers.
    Sørensen HT; Czeizel AE; Rockenbauer M; Steffensen FH; Olsen J
    Acta Obstet Gynecol Scand; 2001 May; 80(5):397-401. PubMed ID: 11328214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do calcium channel blockers increase heart attack risk?
    Johns Hopkins Med Lett Health After 50; 1998 Nov; 10(9):8. PubMed ID: 9803183
    [No Abstract]   [Full Text] [Related]  

  • 10. [Supposedly, calcium channel blockers cause infarction. Then the Bayer company took over the press conference].
    Werkö L
    Lakartidningen; 1995 Oct; 92(43):3982, 3985. PubMed ID: 7475523
    [No Abstract]   [Full Text] [Related]  

  • 11. The safety of calcium-channel blockers.
    Massie BM
    Clin Cardiol; 1998 Dec; 21(12 Suppl 2):II12-7. PubMed ID: 9853194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of calcium channel blockers in cardiovascular disease.
    Langer A
    Circulation; 1998 Dec 22-29; 98(25):2933. PubMed ID: 9860799
    [No Abstract]   [Full Text] [Related]  

  • 13. Reassuring data on calcium channel blockers and cancer.
    Harv Heart Lett; 1998 Jul; 8(11):7. PubMed ID: 9666756
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium-channel blockers and cancer.
    Mann SJ
    Lancet; 1996 Oct; 348(9035):1165; author reply 1167. PubMed ID: 8888182
    [No Abstract]   [Full Text] [Related]  

  • 15. [Increased risk of cancer with calcium antagonists?].
    Lindberg G; Ranstam J; Melander A
    Lakartidningen; 1996 Aug; 93(32-33):2757. PubMed ID: 8765599
    [No Abstract]   [Full Text] [Related]  

  • 16. [Calcium blockers and cancer--is there any link between them?].
    Zimlichman R; Shoenfeld Y
    Harefuah; 1997 Jun; 132(12):876-8. PubMed ID: 9264198
    [No Abstract]   [Full Text] [Related]  

  • 17. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical epidemiology--the risk of impairment].
    Janout V; Janoutová G
    Cas Lek Cesk; 2004; 143(8):565-7. PubMed ID: 15446465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Feared risk factors in connection with calcium antagonists are not to be dismissed].
    Lindberg G; Melander A; Zawadzki A; Jeppsson B
    Lakartidningen; 1998 Apr; 95(17):1905. PubMed ID: 9604634
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of gastrointestinal haemorrhage with calcium antagonists.
    Desboeuf K; Lapeyre-Mestre M; Montastruc JL
    Br J Clin Pharmacol; 1998 Jul; 46(1):88-9. PubMed ID: 9690957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.